← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:738 | 738 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:738 | 738 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:738 | 738 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2417 | 72627-2417-1 | Lysine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:738 | 738 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:739 | 739 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-1 | m-B12 MIC | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:739 | 739 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:739 | 739 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3325 | 62295-3325-5 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3188 | 72627-3188-1 | Hydrocortisone; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-01 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-097 | 73198-097-30 | Lidocaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:739 | 739 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:739 | 739 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-184 | 71449-184-03 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:739 | 739 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:739 | 739 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:740 | 740 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0104 | 71285-0104-1 | Maintenance 4 to 1 Low K (36 mEq) Low Tromethamine 1000ml Bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:740 | 740 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:740 | 740 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:740 | 740 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3171 | 72627-3171-1 | Hydrocortisone; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:740 | 740 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-098 | 73198-098-30 | Lidocaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-0 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:740 | 740 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-802 | 69194-802-01 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-5974 | 72682-5974-1 | Lysine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:740 | 740 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:741 | 741 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2411 | 72627-2411-2 | Coenzyme Q-10 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:741 | 741 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3210 | 72627-3210-1 | Hydrocortisone; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:741 | 741 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:741 | 741 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:741 | 741 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:741 | 741 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:741 | 741 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:742 | 742 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine HCl 1% | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride Anhydrous | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Hydroquinone; Tretinoin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-33 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2001 | 73013-2001-2 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:742 | 742 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:742 | 742 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:743 | 743 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3710 | 72682-3710-1 | Estradiol 10mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride Anhydrous | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Hydroquinone; Tretinoin; Azelaic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3020 | 71286-3020-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2001 | 73013-2001-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:743 | 743 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6010 | 72682-6010-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:743 | 743 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:744 | 744 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine HCl 1% | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Tretinoin; Hydroquinone | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2016 | 73013-2016-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-184 | 71449-184-03 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:744 | 744 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:744 | 744 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2441 | 72627-2441-2 | Methionine; Choline Chloride; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:745 | 745 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-745 | 69194-745-01 | 745 POVIDONE-IODINE 5% BOTTLE | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9998 | 51754-9998-2 | Erythromycin Lactobionate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Tretinoin; Hydroquinone | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-586 | 70092-586-43 | Lidocaine Hydrochloride; Epinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-520 | 69374-520-05 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2000 | 73013-2000-2 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:745 | 745 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:745 | 745 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:746 | 746 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0206 | 72196-0206-1 | Induction 4 to1 High K (48 meq) in RL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Erythromycin; Benzoyl Peroxide | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-35 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2012 | 73013-2012-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-479 | 70092-479-03 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:746 | 746 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:746 | 746 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:747 | 747 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate 200mg/mL 10mL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:747 | 747 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Escitalopram Oxalate; Tadalafil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-16 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:747 | 747 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Guaifenesin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:747 | 747 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2004 | 73013-2004-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-526 | 65302-526-10 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:747 | 747 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:747 | 747 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:747 | 747 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5595 | 26436-5595-3 | Methionine; Inositol; Choline Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:748 | 748 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0427 | 71285-0427-1 | Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:748 | 748 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5550 | 72934-5550-2 | Lidocaine; Mupirocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0112 | 72196-0112-1 | Magnesium Sulfate Heptahydrate; Tromethamine; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Magnesium Chloride; Sodium Acetate; Potassium Chloride; Mannitol | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:748 | 748 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-1 | Methionine; Inositol; Choline Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:749 | 749 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | BLT | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-620 | 70004-620-12 | Esmolol Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:749 | 749 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:749 | 749 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-246 | 70731-246-55 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:749 | 749 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:749 | 749 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5536 | 72934-5536-4 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0219 | 72196-0219-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Sodium Bicarbonate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:749 | 749 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:750 | 750 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-144 | 73198-144-30 | Amino Blend | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:750 | 750 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:750 | 750 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-246 | 70731-246-82 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1213 | 73271-1213-1 | Ketoconazole | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:750 | 750 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-4 | Lidocaine; Tetracaine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:750 | 750 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:751 | 751 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2024-2 | valid | 0 | 2026-09-18 |